CHIO3: Chemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B non-small cell lung cancer (AFT-46)
- Citation:
- J Thorac Oncol vol 16 (3S) S648 P79.06
- Meeting Instance:
- IASLC (WCLC) 2020
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Astra-Zeneca
- Grants:
- AFT
- Corr. Author:
- Authors:
- Linda W. Martin Xiaofei Wang Jyoti D. Patel David Kozono Carly Crocker James Urbanic Everett Vokes Thomas Stinchcombe
- Networks:
- CA249, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC010, VA009
- Study
- AFT-46
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: